Archive for the ‘Types of Cancer’ Category

Easy Steps to Prevent Mesothelioma

Sunday, June 1st, 2008

by: Amie Perlowski Mesothelioma is a rare cancer that attacks the body's mesothelial cells around the organs. The mesothelium provides a protective membranous lining for the internal organs and allows moving organs (i.e. the ...

Choosing a Mesothelioma Doctor

Sunday, June 1st, 2008

by: Peter Lenkefi Mesothelioma Cancer is considered, within the medical profession, to be a serious illness. Mesothelioma Doctors are now available to those who are sufferers of Mesothelioma Cancer. Mesothelioma Doctors are well educated in ...

Can Washington Mesothelioma Attorneys Help My Case?

Sunday, June 1st, 2008

by: Jon Butt Washington Mesothelioma Attorneys have a proven track record when it comes to securing compensation for those that have been wronged by asbestos manufacturers. In fact, most lawsuits filed by Mesothelioma attorneys ...

Avoid Further Mesothelioma Injury Through Prompt Treatment

Sunday, June 1st, 2008

by: Peter Lenkefi Mesothelioma injury can be classified into three main groups, Pleural (chest), Peritoneal (abdominal) and Pericardial (heart). All three types of Mesothelioma injury are mainly cause through exposure to an Asbestos related ...

Asbestos: Cause Of Deadly Mesothelioma

Sunday, June 1st, 2008

by: Kirsten Hawkins A View of Mesothelioma Asbestos is the commercial name given to certain types of fibrous materials. They are silicates of varying compositions; the silica combined with such bases as Magnesium, Iron, Calcium, sodium and Aluminum. Asbestos fibers are usually from 20 to 500  in length and 0.5 to ...

What is Mesothelioma?

Sunday, June 1st, 2008

Mesothelioma is a rare form of cancer in which malignant (cancerous) cells are found in the mesothelium, a protective sac that covers most of the body’s internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles.

IBC Inflammatory Breast Cancer

Sunday, June 1st, 2008



Herceptin Prolongs Progression Free Survival Of HER2 Breast Cancer Patients

Friday, May 30th, 2008

The results of a phase III trial comparing Herceptin with chemo against chemo on its own showed that Herceptin helped women with aggressive metastatic HER2-positive breast cancer live nearly three months longer without their cancer progressing. The findings are being presented this weekend at the 44th annual meeting of the ...